Cambridge Investment Research Advisors’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-1,556
| Closed | -$276K | – | 3475 |
|
2024
Q3 | $276K | Sell |
1,556
-34
| -2% | -$6.03K | ﹤0.01% | 2889 |
|
2024
Q2 | $268K | Sell |
1,590
-99
| -6% | -$16.7K | ﹤0.01% | 2792 |
|
2024
Q1 | $281K | Buy |
1,689
+335
| +25% | +$55.7K | ﹤0.01% | 2750 |
|
2023
Q4 | $224K | Buy |
+1,354
| New | +$224K | ﹤0.01% | 2821 |
|
2023
Q3 | – | Sell |
-1,549
| Closed | -$242K | – | 3148 |
|
2023
Q2 | $242K | Sell |
1,549
-2,649
| -63% | -$414K | ﹤0.01% | 2713 |
|
2023
Q1 | $680K | Sell |
4,198
-6,843
| -62% | -$1.11M | ﹤0.01% | 1863 |
|
2022
Q4 | $1.76M | Buy |
11,041
+207
| +2% | +$33.1K | 0.01% | 1152 |
|
2022
Q3 | $1.53M | Sell |
10,834
-879
| -8% | -$124K | 0.01% | 1202 |
|
2022
Q2 | $1.71M | Sell |
11,713
-1,240
| -10% | -$181K | 0.01% | 1121 |
|
2022
Q1 | $2.1M | Buy |
12,953
+10,429
| +413% | +$1.69M | 0.01% | 1109 |
|
2021
Q4 | $478K | Buy |
2,524
+67
| +3% | +$12.7K | ﹤0.01% | 2138 |
|
2021
Q3 | $497K | Buy |
2,457
+344
| +16% | +$69.6K | ﹤0.01% | 2063 |
|
2021
Q2 | $426K | Sell |
2,113
-212
| -9% | -$42.7K | ﹤0.01% | 2181 |
|
2021
Q1 | $408K | Sell |
2,325
-717
| -24% | -$126K | ﹤0.01% | 2043 |
|
2020
Q4 | $516K | Buy |
3,042
+296
| +11% | +$50.2K | ﹤0.01% | 1751 |
|
2020
Q3 | $445K | Sell |
2,746
-373
| -12% | -$60.4K | ﹤0.01% | 1681 |
|
2020
Q2 | $508K | Buy |
3,119
+1,550
| +99% | +$252K | ﹤0.01% | 1548 |
|
2020
Q1 | $201K | Buy |
+1,569
| New | +$201K | ﹤0.01% | 1932 |
|
2018
Q4 | – | Sell |
-2,284
| Closed | -$311K | – | 2161 |
|
2018
Q3 | $311K | Sell |
2,284
-83
| -4% | -$11.3K | ﹤0.01% | 1777 |
|
2018
Q2 | $284K | Sell |
2,367
-269
| -10% | -$32.3K | ﹤0.01% | 1766 |
|
2018
Q1 | $317K | Buy |
2,636
+34
| +1% | +$4.09K | ﹤0.01% | 1628 |
|
2017
Q4 | $324K | Sell |
2,602
-10,960
| -81% | -$1.36M | ﹤0.01% | 1599 |
|
2017
Q3 | $1.82M | Sell |
13,562
-8,011
| -37% | -$1.07M | 0.02% | 569 |
|
2017
Q2 | $2.71M | Sell |
21,573
-137
| -0.6% | -$17.2K | 0.04% | 409 |
|
2017
Q1 | $2.59M | Sell |
21,710
-729
| -3% | -$86.8K | 0.04% | 381 |
|
2016
Q4 | $2.41M | Sell |
22,439
-6,493
| -22% | -$699K | 0.05% | 383 |
|
2016
Q3 | $3.33M | Buy |
28,932
+25,639
| +779% | +$2.95M | 0.06% | 293 |
|
2016
Q2 | $337K | Buy |
3,293
+450
| +16% | +$46.1K | 0.01% | 1120 |
|
2016
Q1 | $295K | Sell |
2,843
-350
| -11% | -$36.3K | 0.01% | 1179 |
|
2015
Q4 | $405K | Buy |
3,193
+4
| +0.1% | +$507 | 0.01% | 965 |
|
2015
Q3 | $365K | Sell |
3,189
-990
| -24% | -$113K | 0.01% | 928 |
|
2015
Q2 | $564K | Buy |
4,179
+570
| +16% | +$76.9K | 0.02% | 754 |
|
2015
Q1 | $468K | Sell |
3,609
-124
| -3% | -$16.1K | 0.01% | 833 |
|
2014
Q4 | $431K | Buy |
3,733
+247
| +7% | +$28.5K | 0.01% | 850 |
|
2014
Q3 | $369K | Buy |
3,486
+76
| +2% | +$8.05K | 0.01% | 971 |
|
2014
Q2 | $325K | Sell |
3,410
-966
| -22% | -$92.1K | 0.01% | 971 |
|
2014
Q1 | $398K | Buy |
+4,376
| New | +$398K | 0.02% | 821 |
|